MFAP4 and atherosclerosis: This may be due to the release of MFAP4 from VSMCs in the medial layer into the circulation, or the increased elastase activity in atherosclerosis, which reduces elastin content in atherosclerotic vessels, leading to decreased MFAP4 synthesis bound to elastin in the ECM (Wulf-Johansson et al., 2013).